Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770478784354 Cache Key: cqdTagPageBySlug:chronic-lymphocytic-leukemia-cll fetchCache[cqdTagPageBySlug:chronic-lymphocytic-leukemia-cll].expirationTime: falsey fetchCache[cqdTagPageBySlug:chronic-lymphocytic-leukemia-cll]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: -16195 -- Key: cqdTagPageBySlug:molly-dewitt-foy, seconds remaining: -26430 -- Key: cqdPostsByTag:cqd-migrated-tag-20546,1,10, seconds remaining: -26377 -- Key: cqdTagPageBySlug:artificial-intelligence-ai, seconds remaining: -23343 -- Key: cqdPostsByTag:cqd-migrated-tag-21501,2,10, seconds remaining: -23282 -- Key: cqdTagPageBySlug:ischemic-mitral-regurgitation, seconds remaining: -20584 -- Key: cqdPostsByTag:cqd-migrated-tag-8685,1,10, seconds remaining: -20540 -- Key: cqdTagPageBySlug:dual-suspensory-fixation, seconds remaining: -20331 -- Key: cqdPostsByTag:cqd-migrated-tag-23955,1,10, seconds remaining: -20284 -- Key: cqdTagPageBySlug:sagar-khanna, seconds remaining: -19063 -- Key: cqdPostsByTag:cqd-migrated-tag-26656,1,10, seconds remaining: -18998 -- Key: cqdTagPageBySlug:johannes-wolff, seconds remaining: -16476 -- Key: cqdPostsByTag:cqd-migrated-tag-1001,1,10, seconds remaining: -16430 -- Key: cqdTagPageBySlug:chronic-rhinosinusitis-crs, seconds remaining: -16195 -- Key: cqdPostsByTag:cqd-migrated-tag-1863,1,10, seconds remaining: -16137 -- Key: cqdTagPageBySlug:hpv-vaccine, seconds remaining: -14416 -- Key: cqdPostsByTag:cqd-migrated-tag-20607,1,10, seconds remaining: -14361 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:chronic-lymphocytic-leukemia-cll - retrieving from Sanity CCCache.dataFetchCount: 6774 Cache cleanup seconds remaining: 30000
Advertisement
Advertisement
Tag: chronic lymphocytic leukemia (CLL)
Discussing research into improving CAR T-cell therapy efficacy
Real-world study shows high response rates that are durable with commercial lisocabtagene maraleucel
Large trial shows efficacy and lower incidences of heart issues and bleeding events with novel non-covalent BTK inhibitor
Regular surveillance necessary to identify safety signals
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Rendered: Sat Feb 07 2026 15:39:44 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.